Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Cell Biol
1991 Feb 01;112:604-10. doi: 10.1128/mcb.11.2.604-610.1991.
Show Gene links
Show Anatomy links
mos gene transforming efficiencies correlate with oocyte maturation and cytostatic factor activities.
Yew N
,
Oskarsson M
,
Daar I
,
Blair DG
,
Vande Woude GF
.
???displayArticle.abstract???
The mos proto-oncogenes from different vertebrate species transform mouse NIH 3T3 cells with markedly different efficiencies. v-mos, mouse (c-mosmu), and chicken (c-mosch) mos transform NIH 3T3 cells 10- to 100-fold more efficiently than do human (c-moshu) and Xenopus (c-mosxc) mos. The mos genes with the highest transforming activity efficiently induce maturation in Xenopus oocytes and mimic cytostatic factor (CSF) by causing mitotic cleavage arrest in embryos. Chimeric v-mos/c-moshu proteins that had high transforming efficiencies in NIH 3T3 cells were also effective in the induction of oocyte maturation and CSF cleavage arrest. We measured the in vitro autophosphorylation activities of the different mos proteins and found that the levels of kinase activity of v-mos, c-mosmu, and c-mosch were much higher than that of c-mosxc. These data indicate that mos gene transforming efficiency and the ability to induce oocyte maturation or mimic CSF activity are correlated with in vitro autophosphorylation activity and suggest that the mos protein plays a similar role in transformed cells and normal oocytes.
Blair,
Activation of the transforming potential of a normal cell sequence: a molecular model for oncogenesis.
1981, Pubmed
Blair,
Activation of the transforming potential of a normal cell sequence: a molecular model for oncogenesis.
1981,
Pubmed
Blair,
Analysis of the transforming potential of the human homolog of mos.
1986,
Pubmed
Draetta,
Cdc2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF.
1989,
Pubmed
Dumont,
Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals.
1972,
Pubmed
,
Xenbase
Dunphy,
The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis.
1988,
Pubmed
,
Xenbase
Freeman,
Transforming mutant v-mos protein kinases that are deficient in in vitro autophosphorylation.
1989,
Pubmed
Freeman,
Effects of the v-mos oncogene on Xenopus development: meiotic induction in oocytes and mitotic arrest in cleaving embryos.
1990,
Pubmed
,
Xenbase
Freeman,
Xenopus homolog of the mos protooncogene transforms mammalian fibroblasts and induces maturation of Xenopus oocytes.
1989,
Pubmed
,
Xenbase
Gautier,
Purified maturation-promoting factor contains the product of a Xenopus homolog of the fission yeast cell cycle control gene cdc2+.
1988,
Pubmed
,
Xenbase
Gerhart,
Cell cycle dynamics of an M-phase-specific cytoplasmic factor in Xenopus laevis oocytes and eggs.
1984,
Pubmed
,
Xenbase
Herzog,
v-mos protein produced by in vitro translation has protein kinase activity.
1990,
Pubmed
Kipreos,
Differential phosphorylation of c-Abl in cell cycle determined by cdc2 kinase and phosphatase activity.
1990,
Pubmed
Kozak,
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.
1986,
Pubmed
Masui,
Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes.
1971,
Pubmed
Maxwell,
Serine kinase activity associated with Maloney murine sarcoma virus-124-encoded p37mos.
1985,
Pubmed
Meijer,
Cyclin is a component of the sea urchin egg M-phase specific histone H1 kinase.
1989,
Pubmed
Morgan,
Mitosis-specific phosphorylation of p60c-src by p34cdc2-associated protein kinase.
1989,
Pubmed
,
Xenbase
Murray,
Cyclin synthesis drives the early embryonic cell cycle.
1989,
Pubmed
,
Xenbase
Nurse,
Universal control mechanism regulating onset of M-phase.
1990,
Pubmed
O'Keefe,
Microinjection of antisense c-mos oligonucleotides prevents meiosis II in the maturing mouse egg.
1989,
Pubmed
Papkoff,
Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus.
1982,
Pubmed
Paules,
Mouse Mos protooncogene product is present and functions during oogenesis.
1989,
Pubmed
,
Xenbase
Roy,
The cyclin B2 component of MPF is a substrate for the c-mos(xe) proto-oncogene product.
1990,
Pubmed
,
Xenbase
Sagata,
The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs.
1989,
Pubmed
,
Xenbase
Sagata,
The product of the mos proto-oncogene as a candidate "initiator" for oocyte maturation.
1989,
Pubmed
,
Xenbase
Sagata,
Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes.
1988,
Pubmed
,
Xenbase
Schmidt,
Chicken homolog of the mos proto-oncogene.
1988,
Pubmed
Seth,
Nucleotide sequence and biochemical activities of the Moloney murine sarcoma virus strain HT-1 mos gene.
1985,
Pubmed
Shenoy,
Purified maturation promoting factor phosphorylates pp60c-src at the sites phosphorylated during fibroblast mitosis.
1989,
Pubmed
,
Xenbase
Singh,
p37mos-associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos.
1986,
Pubmed
Singh,
The histidine-221 to tyrosine substitution in v-mos abolishes its biological function and its protein kinase activity.
1988,
Pubmed
Smith,
Measurement of protein using bicinchoninic acid.
1985,
Pubmed
Towbin,
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
1979,
Pubmed
Watson,
Human DNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virus.
1982,
Pubmed
Wood,
Mouse c-mos oncogene activation is prevented by upstream sequences.
1984,
Pubmed
